Faculty of 1000 evaluation for Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study.

Andrea Pace, Cherubino Di Lorenzo
  • Faculty of 1000, Ltd.
  • DOI: 10.3410/f.2748958.2444054
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr Cherubino Di Lorenzo